Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.
D000230:Adenocarcinoma / Q000276:immunology* / Q000628:therapy; D000368:Aged; D000917:Antibody Formation; D001943:Breast Neoplasms / Q000276:immunology* / Q000628:therapy; D002277:Carcinoma / Q000276:immunology* / Q000628:therapy; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000276:immunology* / Q000628:therapy; D003110:Colonic Neoplasms / Q000276:immunology* / Q000628:therapy; D003429:Cross Reactions; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D007118:Immunoassay; D007156:Immunologic Memory; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008545:Melanoma / Q000276:immunology* / Q000628:therapy; D008875:Middle Aged
D007106:Immune Sera